Navigation Links
STAAR Surgical to Present at the Noble Financial Equity Conference
Date:8/11/2008

MONROVIA, Calif., Aug. 11 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, announced today that it will present at the at the upcoming Fourth Annual Noble Financial Equity Conference which will be held Monday, August 18th - Tuesday, August 19th, 2008 at the Loews Lake Las Vegas Resort, Nevada. Barry G. Caldwell, President and Chief Executive Officer will discuss the Company's business strategy and historical financial performance at 11:00 a.m. Pacific Time on Monday, August 18th.

A live audio webcast of STAAR Surgical's presentation may be accessed through the Company's website at http://www.staar.com. The presentation will feature high-definition, streaming video and PowerPoint slides. It is recommended that interested parties register 15 minutes prior to the start of the presentation to ensure timely access. An archived replay of the presentation will be available after the live presentation, and can also be accessed at http://www.staar.com.

About STAAR Surgical

STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the Visian ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the FDA for use in treating myopia, has received CE Marking and is sold in more than 40 countries. Collamer(R) is the brand name for STAAR's proprietary collagen copolymer lens material. More information is available at http://www.staar.com.

CONTACT: Investors Media

EVC Group EVC Group

Dahlia Bailey, 415-896-5862 Steve DiMattia 646-201-5445


'/>"/>
SOURCE STAAR Surgical Company
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. STAAR Surgicals Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification
2. STAAR Surgicals LASIK Alternative Expands U.S. Market Gains
3. STAAR Surgical Reports Solid First Quarter Progress
4. STAAR Surgical Announces First Quarter 2008 Earnings Release Date and Conference Call
5. STAAR Surgical Plans Major Presence at ASCRS
6. STAAR Surgical Reports Fourth Quarter and Year End Results
7. STAAR Surgicals Visian ICL Procedure Performed Live on NBCs Today show
8. STAAR Surgical Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call
9. STAAR Surgical to Present at the Tenth Annual Needham Growth Conference
10. STAAR Surgical Completes $5M Debt Financing for Purchase of Japanese Joint Venture
11. STAAR Surgical to Present at the BMO Capital Markets Focus on Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: